IP Library › Granted Patent US 8,043,628
Granted Patent B2
US 8,043,628 · App. 11/932,181 · Granted Oct 25, 2011

Methods for reducing edema

Assignee: Allergan, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,043,628
App. No.
11/932,181
Granted
Oct 25, 2011
Kind
B2
Abstract

Methods for reducing or preventing neovascularization or edema in the eye by implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.

Claims (4)

1. A method for treating edema in an eye, comprising: placing a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer in an eye of an individual, thereby treating edema of the eye, wherein the placing comprises placing the bioerodible drug delivery system in the vitreous of the eye.

2. The method of claim 1 , wherein the bioerodible polymer comprises a polylactic acid polyglycolic acid (PLGA) copolymer.

3. The method of claim 1 , wherein the bioerodible drug delivery system delivers the immunosuppressive agent for at least about 5 days.

4. The method of claim 1 , wherein the bioerodible drug delivery system delivers the immunosuppressive agent for at least about 3 weeks.

Continuity (8)
Continuation 11852223 · Sep 7, 2007
Division 11738409 · Apr 20, 2007
Division 11180079 · Jul 11, 2005
Continuation 10744560 · Dec 22, 2003
Continuation 09997094 · Nov 28, 2001
Provisional Application 60298253 · Jun 12, 2001
Provisional Application 60250023 · Nov 29, 2000
Related Publication 20080050420A1 · Feb 28, 2008